Terms: = Uterine cancer AND MAX, MGC36767, 4149, ENSG00000125952, MGC18164, MGC10775, P61244, MGC11225, orf1, MGC34679
225 results:
1. [
Adam JA; Poel E; van Eck Smit BLF; Mom CH; Stalpers LJA; Laan JJ; Kidd E; Stoker J; Bipat S
BMC Cancer; 2024 Apr; 24(1):513. PubMed ID: 38654241
[TBL] [Abstract] [Full Text] [Related]
2. Tumor and metastatic lymph nodes metabolic activity on
Song J; Pang W; Yi H; Ji J; Ye X; Li L
Abdom Radiol (NY); 2024 Mar; 49(3):975-984. PubMed ID: 38302763
[TBL] [Abstract] [Full Text] [Related]
3. Knowledge and Perceptions of Cervical cancer Screening in Nhlambeni, Eswatini: Understanding Facilitators and Barriers for Prevention Interventions.
Maseko T; Tsoka-Gwegweni JM; Ndirangu J; Okello V; Dlamini X
West Afr J Med; 2023 Dec; 40(12):1325-1331. PubMed ID: 38261526
[TBL] [Abstract] [Full Text] [Related]
4. Long-term assessment of clinical parameters and positron emission tomography parameters in predicting recurrence in uterine cervical cancer patients receiving definitive chemoradiotherapy.
Onal C; Guler OC; Torun N; Reyhan M
Nucl Med Commun; 2024 Mar; 45(3):203-210. PubMed ID: 38165168
[TBL] [Abstract] [Full Text] [Related]
5. A prospective single-arm study on the relationship between dose-volume parameters of pelvic functional bone marrow and acute hematological toxicities during intensity-modulated radiotherapy with or without concurrent chemotherapy for uterine cervical/endometrial cancer.
Chen H; Zhong Q; Liu Y; Li J; Deng W; Wang J; Zhou S; Yu Z; Huang X; Huang Y; Zhen B; Wei J; Zhang W; Ruan X; Xiao L
Radiat Oncol; 2023 Nov; 18(1):193. PubMed ID: 38012675
[TBL] [Abstract] [Full Text] [Related]
6. Clinical relevance of circulating ESR1 mutations during endocrine therapy for advanced hormone-dependent endometrial carcinoma.
Drouyer A; Beaussire L; Jorda P; Leheurteur M; Guillemet C; Berghian A; Georgescu D; Di Fiore F; Perdrix A; Clatot F
BMC Cancer; 2023 Nov; 23(1):1061. PubMed ID: 37924026
[TBL] [Abstract] [Full Text] [Related]
7. MRI-based radiomic signatures for pretreatment prognostication in cervical cancer.
Wagner-Larsen KS; Hodneland E; Fasmer KE; Lura N; Woie K; Bertelsen BI; Salvesen Ø; Halle MK; Smit N; Krakstad C; Haldorsen IS
Cancer Med; 2023 Oct; 12(20):20251-20265. PubMed ID: 37840437
[TBL] [Abstract] [Full Text] [Related]
8. Head-to-Head Comparison of 18 F-FDG and 68 Ga-FAPI-04 PET/CT for Radiological Evaluation of Cervical cancer.
Shu Q; He X; Chen X; Liu M; Chen Y; Cai L
Clin Nucl Med; 2023 Nov; 48(11):928-932. PubMed ID: 37756446
[TBL] [Abstract] [Full Text] [Related]
9. PET/MRI in Endometrial cancer: Imaging Biomarkers are Associated with Disease Progression and Overall Survival.
Shih IL; Yen RF; Chen CA; Cheng WF; Chen BB; Zheng QY; Cheng MF; Chen JL; Shih TT
Acad Radiol; 2024 Mar; 31(3):939-950. PubMed ID: 37714718
[TBL] [Abstract] [Full Text] [Related]
10. Radioguided surgery with β decay: A feasibility study in cervical cancer.
Collarino A; Florit A; Bizzarri N; Lanni V; Morganti S; De Summa M; Vizzielli G; Fanfani F; Mirabelli R; Ferrandina G; Scambia G; Rufini V; Faccini R; Collamati F
Phys Med; 2023 Sep; 113():102658. PubMed ID: 37603908
[TBL] [Abstract] [Full Text] [Related]
11. Whole-Lesion Apparent Diffusion Coefficient Histogram Analysis for Assessing Normal-Sized Lymph Node Metastasis in Cervical cancer: Comparison Between Readout-Segmented and Single-Shot Echo-Planar Diffusion-Weighted Imaging.
Qian W; Chen Q; Hu C
J Comput Assist Tomogr; 2023 Jul-Aug 01; 47(4):554-560. PubMed ID: 37380155
[TBL] [Abstract] [Full Text] [Related]
12. Value of [
Burchardt E; Bos-Liedke A; Serkowska K; Cegla P; Piotrowski A; Malicki J
Sci Rep; 2023 Jun; 13(1):9092. PubMed ID: 37277546
[TBL] [Abstract] [Full Text] [Related]
13. Asphericity derived from [
Cegla P; Hofheinz F; Burchardt E; Czepczyński R; Kubiak A; van den Hoff J; Nikulin P; Bos-Liedke A; Roszak A; Cholewinski W
Sci Rep; 2023 May; 13(1):8423. PubMed ID: 37225735
[TBL] [Abstract] [Full Text] [Related]
14. T1 mapping and multimodel diffusion-weighted imaging in the assessment of cervical cancer: a preliminary study.
Li S; Liu J; Zhang W; Lu H; Wang W; Lin L; Zhang Y; Cheng J
Br J Radiol; 2023 Aug; 96(1148):20220952. PubMed ID: 37183908
[TBL] [Abstract] [Full Text] [Related]
15. Prognostic value of apparent diffusion coefficient in neuroendocrine carcinomas of the uterine cervix.
Chen J; Ma N; Sun M; Chen L; Yao Q; Chen X; Lin C; Lu Y; Lin Y; Lin L; Fan X; Chen Y; Wu J; He H
PeerJ; 2023; 11():e15084. PubMed ID: 37020850
[TBL] [Abstract] [Full Text] [Related]
16. Circulating Tumor Cell Detection by Liquid Biopsy during Early-Stage Endometrial cancer Surgery: A Pilot Study.
Francini S; Duraes M; Rathat G; Macioce V; Mollevi C; Pages L; Ferrer C; Cayrefourcq L; Alix-Panabières C
Biomolecules; 2023 Feb; 13(3):. PubMed ID: 36979364
[TBL] [Abstract] [Full Text] [Related]
17. A Pilot Study of a Screening Program for Human Papillomavirus-Related Squamous Intraepithelial Lesion and Malignancy in Gynecologic Oncology Patients.
Watson CH; Spinosa D; Hayes T; Scott A; Jackson L; Thacker JK; Sherman KL; Moss HA; Havrilesky LJ; McNally JL
J Low Genit Tract Dis; 2023 Apr; 27(2):120-124. PubMed ID: 36745862
[TBL] [Abstract] [Full Text] [Related]
18. Response to first line platinum-based chemotherapy in mismatch repair deficient (MMRd)/ microsatellite instability high (MSI-high) endometrial carcinoma.
Colomba E; Alexandre J; Le Teuff G; Genestie C; Coupez D; Coquard IR; Brachet PE; de Percin S; Sajous C; Fabbro M; Delanoy N; Joly F; Frenel JS; Pautier P; Leary A
Gynecol Oncol; 2023 Feb; 169():78-84. PubMed ID: 36521352
[TBL] [Abstract] [Full Text] [Related]
19. Dosimetric analysis of intensity-modulated radiation therapy and volumetric-modulated arc therapy in comparison with conventional box technique in the treatment of carcinoma cervix: An impact of prosthetic implant.
Bhushan M; Tripathi D; Yadav G; Kumar L; Chowdhary RL; Pahuja AK; Suhail M; Mitra S; Gairola M
J Cancer Res Ther; 2022; 18(6):1504-1512. PubMed ID: 36412401
[TBL] [Abstract] [Full Text] [Related]
20. ARID1A, BRG1, and INI1 deficiency in undifferentiated and dedifferentiated endometrial carcinoma: a clinicopathologic, immunohistochemical, and next-generation sequencing analysis of a case series from a single institution.
Korentzelos D; Elishaev E; Zhao C; Jones MW; Soong TR; Lesnock J; Orellana T; Zeccola A; Diamantopoulos LN; Wald AI; Bhargava R
Hum Pathol; 2022 Dec; 130():65-78. PubMed ID: 36252860
[TBL] [Abstract] [Full Text] [Related]
[Next]
